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Abstract
Hypersensitive site 5 (59HS5) of the b-globin Locus Control Region functions as a developmental stage-specific border in
erythroid cells. Here, we have analyzed the role of 59HS5 in the three dimensional organization of the b-gene locus using the
Chromatin Conformation Capture (3C) technique. The results show that when 59HS5 is deleted from the locus, both remote
and internal regulatory elements are still able to interact with each other in a three-dimensional configuration termed the
Active Chromatin Hub. Thus, the absence of 59HS5 does not have an appreciable effect on the three dimensional
organization of the b-globin locus. This rules out models in which 59HS5 nucleates interactions with remote and/or internal
regulatory elements. We also determined the binding of CTCF, the only defined insulator protein in mammalian cells, to
59HS5 by using chromatin immunoprecipitation (ChIP) assays. We detect low levels of CTCF binding to 59HS5 in primitive
erythroid cells, in which it functions as a border element. Surprisingly, we also observe binding levels of CTCF to 59HS5 in
definitive erythroid cells. Thus, binding of CTCF to 59HS5 per se does not render it a functional border element. This is
consistent with the previous data suggesting that CTCF has dual functionality.
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Introduction
The human b-globin locus contains five genes that are arranged
in the same order as their developmental expression pattern: 59-e
(embryonic) Gc Ac (foetal) d b (adult)-39. The major activating
region, termed the Locus Control Region (LCR), is located 6 to
22 kb 59 to the e-globin gene. The most prominent charactistic of
the human b-globin LCR is that it drives high level, tissue-specific,
copy number-dependent and position-independent expression of
linked transgenes in mice [1]. The core components of the LCR
are the DNase I hypersensitive sites (59HS1-5) [2]. Each of the
hypersensitive sites holds a unique array of transcription factor
binding sites, including those for GATA1, NF-E2 and EKLF
proteins. This suggests that the HS in the human LCR may have
different stage-specific activities and cannot be replaced function-
ally by each other [3,4]. Transcriptional activation of the b-like
globin genes is thought to be a multi-step system. This model
includes the active involvement of erythroid transcription factors
in the spatial organization of the locus, and increased accessibility
to trans-acting factors by recruitment of chromatin remodeling
complexes [5]. The resultant transcriptionally active locus is
arranged in a three dimensional structure termed the active
chromatin hub (ACH), in which the LCR hypersensitive sites
interact directly with the transcribed genes through a looping
mechanism [6,7]. The deduced spatial arrangement of the
regulatory elements and the genes in the ACH offers an
explanation for the observation that a gene proximal to the
LCR has a transcriptional advantage over a more distally located
gene [8,9]. The mode of action of the LCR to the b-globin genes
appears to be orientation dependent as an inverted LCR is
incapable of activating downstream globin genes at high levels,
and the e-gene can not be activated when placed upstream of the
LCR [10]. This property of the LCR may be due to the spatial
organization of its hypersensitive sites, but it is also possible that
the locus contains elements that block LCR action in one of the
directions [11].
Recently, we have shown that human 59HS5 acts as a
developmental stage-specific border element in erythroid cells. In
that study, we placed a marked b-globin gene upstream of the LCR
and the genes, using PAC constructs of the human b-globin locus in
which 59HS5 was flanked by loxP sites [11].
In the present study, we applied Chromosome Conformation
Capture (3C) technology to further investigate the functional
properties of 59HS5 in vivo. The rationale behind the use of the 3C
technique was to delineate the spatial organization of the b-globin
locus upon Cre/loxP-mediated deletion of 59HS5 in human b-
globin transgenes in mice. To date, directionality of the LCR has
not yet been studied using the 3C technique in the context of the
three-dimensional structure of the human b-globin locus. 3C
analysis of the human b-globin transgenes was performed at the
primitive and definitive stages of erythropoiesis. Since 59HS5
functions as a border in primitive erythroid cells, any major
alterations in the 3D organization of the locus related to this
property should be revealed. We also performed 3C analysis in the
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same transgenic lines in which 59HS5 had been removed by Cre-
mediated excision.
The first insulator element reported in vertebrates is 59HS4
(cHS4) in the chicken b-globin locus [12]. Binding of the 11 Zn-
finger protein CTCF to the FII region of the cHS4 is thought to
play an important role in the activity of cHS4 [13,14]. To
investigate the potential activity of CTCF as an enhancer blocking
protein on human 59HS5 in vivo, we performed chromatin
immunoprecipitation assays using antibodies directed against
CTCF.
Results
PAC constructs for 3C analysis of the human b-globin
locus
To examine the potential conformational changes of the ACH
in the presence or absence of 59HS5 in the context of the human
b-globin locus, we employed transgenic mice carrying modified
human b-globin PAC transgenes (Fig. 1, [11]). The transgenes
were derived from PAC185 which contains the entire human b-
globin gene cluster. Homologous recombination in E. coli DH10B
cells [15] was used for generation of the constructs. To determine
the effect of deletion of 59HS5 on the three dimensional (3D)
organization of the locus, 59HS5 was flanked by loxP sites to
enable Cre-mediated deletion of 59HS5 (PACD1B). The basal
promoter and 59 untranslated regions of the b-globin gene, from
2139 to +49 relative to the cap site of the gene, has been removed
to generate the b-globin promoter deletion (PAC3K; Fig. 1).
Intactness of the transgenes was carefully mapped by Southern
blot analysis using a total of 11 different restriction enzymes and
hybridization with cosmid LCRe, -ccdb probes [16], and smaller
probes along the b-globin locus [11].
3C analysis of the PAC constructs with the bm gene and
59HS5 flanked by loxP sites
Previous studies on human b-globin transgenes in mice have
shown that the b-globin gene interacts with the ACH when it is
transcribed in definitive erythroid cells [7]. In these studies, the
Chromosome Conformation Capture (3C) technique [6,7,17] was
used to examine the three dimensional organization of the b-globin
locus. First, we determined whether introduction of the b-marked
(bm) gene, which is an artificially modified b-globin gene with part
of its exon 2 replaced by equivalent Ac-globin gene [9] (Fig. 1B),
and flanking 59HS5 by loxP sites per se caused conformational
changes of the b-globin locus. We performed 3C analysis on the
PAC transgenes and compared this directly to the results obtained
with the wild type locus (PAC8.1; Fig. 2). In the wild type locus,
59HS1-5 of the LCR and the HS in the 39 flanking region (39HS1)
interact with each other to form the ACH of the b-globin locus.
The results of 3C analysis on the PAC1B transgene show that the
spatial structure of the locus is basically unaltered when compared
with that of wild type PAC8.1. In brain, a non-erythroid tissue, the
PAC transgene shows an essentially linear conformation of the b-
globin locus (data not shown). This is consistent with the notion that
the formation of ACH is tissue specific [6].
Figure 1. Schematic presentation of the human b-globin locus in PAC transgenic constructs. A) Arrows on top of the locus depict the
individual hypersensitive sites within the LCR. b-like globin genes are indicated by large triangles with different colors. The b-mark globin gene was
indicated by light blue rectangle with bm labeled on top of it. LTR located at the 59-upstream of the bm gene was indicated by the small rectangle
with black in color. The HS5 is flanked by loxP sites indicated by small triangle on the locus. PACD constructs were generated by homologous
recombination according to Iman et al., 2000. The white boxes indicate the olfactory receptor (OR) genes which flank the b-globin locus. HindIII
restriction sites (small arrows) and the DNA fragments used in the 3C analysis (solid rectangles) are shown below the PAC1B locus. Distances are in kb
counting from the transcription initiation site of the e-globin gene. B) Structure of the marked b-globin gene (bm) and the ChIP-bm primers location.
doi:10.1371/journal.pone.0002134.g001
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Effect of the deletion of the 59HS5 on ACH formation
To study the effect of 59HS5 on the spatial organization of the
b-globin locus, we compared the PAC1B line with the PACD1B
line, in which 59HS5 had been deleted by the action of Cre
recombinase [15].
It has been proposed that transcriptional activation of b-like
globin genes at each stage of development is a multi-step
process [5]. An LCR holocomplex is formed to allow the
accessibility of transcription and chromatin remodeling factors to
the locus, thus providing a high local concentration of the relevant
trans-acting factors for efficient transcription. The resultant
functional active chromatin hub (ACH) comprises the LCR
holocomplex interacting directly with the transcribed genes
[6,7,18]. This model implies that maintaining the integrity of the
ACH is the key to create a chromatin domain permissive for
transcriptional regulation.
To examine the possible consequences of deletion of 59HS5 on
ACH formation, we compared the 3D structures of the PAC1B
and PACD1B transgenes in definitive erythroid cells isolated from
14.5 dpc fetal livers with the 3C technique (Fig. 3). The results
show that the overall 3D of the b-globin locus has remained the
same when 59HS5 is deleted (PACD1B). However, the relative
crosslinking frequency of the 59HS6, the distal hypersensitive site
located about 6 kb 59 upstream to the HS5 [19], with the b-globin
gene is increased by upon the removal of 59HS5 (Fig. 3B, primer
418). This increase in association frequency with the ACH is
presumably due to the closer proximity of 59HS6 to the LCR after
Cre-mediated excision of 59HS5. 59HS6 is located 800bp closer to
the LCR in the PACD1B line. Besides, in the absent of HS5, the b-
gene promoter interacts strongly with the A-c promoter.
In mammals, two developmental switches of hematopoiesis
occur during ontogeny. In transgenic mice carrying the human b-
Figure 2. 3C analysis of the PAC1B transgene using a primer from the human b-globin gene in combination with primers from other
parts of the locus. Fetal livers were collected from E14.5 embryos for this set of 3C experiments. (A) Representative examples of the PCR fragments
resulting from the 3C experiments. WT: PAC8.1wt; RT: Random template control. (B) Histogram of the relative crosslinking efficiencies after
quantitation and normalization. The histograms are the average of at least three separate experiments, with each PCR performed in triplicate.
doi:10.1371/journal.pone.0002134.g002
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globin locus, yolk sac-derived primitive erythroid cells express the
human embryonic e- and fetal c-globin genes [16]. b-like globin
gene expression switches to the fetal c- and adult d- and b-globin
genes during early definitive erythropoiesis between E12.5 and
E14.5. The LCR plays an important role in the regulation of
expression of the b-like globins, and the order and distance of the
genes relative to the LCR are important parameters for the
developmental switch [8,9,20]. These developmental switches of
hematopoiesis are accompanied by changes in chromatin structure
and spatial organization of regulatory elements throughout the
locus [6,7,21]. In a previous study with the human b-globin PAC
transgenes we have shown that 59HS5 functions as an enhancer
blocker in embryonic erythroid cells [11]. Therefore, it is
interesting to determine the possible conformational changes of
the locus without 59HS5 in embryonic erythroid cells.
PAC3K transgenic lines, in which the promoter of the b-globin
gene in the normal position is deleted, have been used for the 3C
analysis. The rationale behind the usage of the PAC3K construct
for performing the 3C analysis is that in this configuration, the bm
gene located upstream of the LCR is maximally activated in
definitive cells, while expression in primitive cells is only detectable
after deletion of 59HS5. We therefore compared the locus-wide
crosslinking frequencies of the PAC3K and PACD3K (PAC
construct with deletion of 59HS5) transgenes at different
developmental stages. In the fetal liver, we observed that the 3D
conformation of the PAC3K and PACD3K transgenes is virtually
identical to that observed for the PAC1B and PACD1B transgenes
(data not shown). This implies that neither 59HS5 nor the b-globin
promoter is required for structural changes in the ACH occurring
during the process of b-globin gene switching [7,18,22]. The latter
Figure 3. 3C analysis of the PAC1B and PACD1B transgenic lines using a primer from the human b-globin gene in combination with
primers from other parts of the locus. Fetal livers were collected from E14.5 embryos for this set of 3C experiments. (A) Representative examples
of the PCR fragments resulting from the 3C experiments. (B) Histogram of the relative crosslinking efficiencies after quantitation and normalization.
The histograms are the average of at least three separate experiments, with each PCR performed in triplicate.
doi:10.1371/journal.pone.0002134.g003
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is in agreement with Patrinos et al. [23] who have shown that
deletion of the b-globin promoter alone is not sufficient to alter the
3D configuration of the ACH.
Since 59HS5 functions as a border at the primitive stage [11], we
next examined the spatial organization of the PAC3K and PACD3K
transgenes in embryonic blood samples. The restriction fragment
containing 59HS2 [24], a classical enhancer element within the
LCR, was used as the fixed fragment for the results presented in
Fig. 4. The analysis shows that the spatial organization of the locus is
basically unchanged upon deletion of 59HS5 (PACD3K) when
compared with the PAC3K transgenic line. In agreement with the
notion that the c-globin gene is predominantly expressed in primitive
cells, higher relative crosslinking frequencies of the c-globin gene
compared to the b-globin gene could be observed (Fig. 4). The results
imply that in primitive erythroid cells association of the actively
transcribed c-globin genes with the ACH principally remains the
same in the absence of 59HS5.
For investigating the spatial organization of the chromatin hub
(CH), which can be observed in the erythroid progenitor cells
without b-like globin gene expression [7], we used the b-globin gene
as the fixed primer in 3C analysis (Fig. 5). Similar results were
obtained between the two constructs (PAC3K vs. PACD3K). In
conclusion, the results strongly indicate that deletion of 59HS5 of
the LCR in the human transgene does not have a measurable
effect on the 3 dimensional organization of the b-globin locus,
neither in the primitive stage where 59HS5 functions as a border
or enhancer blocker, nor in the definitive stage where 59HS5 does
not have a known function.
ChIP analysis of CTCF binding to 59HS5 in primitive and
definitive erythroid cells
We have shown previously that human 59HS5 has an enhancer
blocking function at the primitive stage [11]. However, the mecha-
nism by which this function is achieved remains unknown. Although
a number of enhancer blocking proteins have been identified in
Drosophila [25–27], CTCF is the only protein known so far to mediate
enhancer blocking activity in vertebrates [28,29]. Previous studies
conducted by Felsenfeld and his colleagues have described a 1.2kb
DNA element with strong enhancer blocking activity, located at the
59HS4 of the chicken b-globin gene locus [28,29].
A 250bp core fragment of the cHS4 is fully functional and a
single binding site for the protein CTCF, FII, is necessary and
sufficient to block the action of an enhancer on a promoter when
placed between them [30]. Conserved CTCF binding sites are
found at 59HS5 and 39HS1 of both the mouse and human loci.
To investigate whether CTCF binds to 59HS5, ChIP analysis
using an antibody to CTCF was performed (Fig. 6). The CTCF
ChIP DNA enrichment levels of three fragments were tested,
namely, mouse endogenous HS62 (mHS62), human bm (the
marked b-globin gene) and human 59HS5. In erythroid tissues,
DNA enrichment could be detected by real-time PCR. Our results
on mHS62 are in agreement with a previous study [14] and
confirm that CTCF binds to the endogenous mouse HS62
fragment. Human 59HS5 exhibits only modest enrichment levels
of 1.5 fold at primitive and 2.4 fold at definitive stages. These
results support the previous in vitro assay data [13] showing the
presence of a CTCF binding site in human 59HS5 [13]. Our data
suggest that CTCF also binds to human HS5 in vivo.
Simultaneously, the bm gene enrichment level was determined
using anti-CTCF ChIP assay. Surprisingly, the DNA enrichment
level of bm gene is higher than that of the human 59HS5 and
mouse HS62 at both developmental stages (Fig. 6). Further studies
are needed to characterize the functional role of CTCF binding to
the bm gene.
Discussion
In this study, we have analyzed the role of 59HS5 with respect to
the three dimensional configuration of the human b-globin locus.
The transgenic lines carried PAC constructs that were derived from
the original 185 kb human b-globin PAC [7]. Transgenic lines
carrying single copies of four modified PAC constructs, namely
PAC1B, PACD1B, PAC3K and PACD3K, were used [15] to
determine possible conformational changes of the locus after
deletion of the 59HS5 core region. The 3D conformation of the
transgenic loci was determined by 3C analysis. A human b-globin
promoter deletion in the context of the full LCR was used to
determine whether or not the interaction between the b-globin gene
and the LCR would be perturbed when both 59HS5 and the b-
globin promoter (PACD3K) were deleted, as was previously found
when both 59HS3 and the b-globin promoter were deleted [23].
We analyzed the conformation of the globin transgenes from two
important genomic sites in the human b-globin locus, namely the b-
globin gene and 59HS2. We first examined the integrity of the ACH
upon the removal of 59HS5 in the PACD1B transgenic line at the
definitive stage. The results show that the three dimensional
Figure 4. 3C analysis of the PAC3K and PACD3K transgenes
using a primer from 59HS2 as the fixed primer. Embryonic blood
was collected from E10.5 embryos for this set of 3C experiments. (A)
Representative examples of the PCR fragments resulting from the 3C
experiments. RT: Random template control. (B) Histogram of the relative
crosslinking efficiencies after quantitation and normalization.
doi:10.1371/journal.pone.0002134.g004
h59HS5 Is b-ACh Dispensable
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structure of the b-globin locus has essentially remained the same
when 59HS5 is deleted. Mild increments of the association frequency
of 59HS6 to the LCR could be explained by distance effects [9]:
59HS6 interacts more frequently with the ACH once it moves closer
to the LCR after Cre-mediated excision of 59HS5. This is consistent
with our previous data on human b-globin transgenic mice which
showed that the increase in expression of the bm gene, which is
located 59 upstream of the LCR, is likely due to the shorter distance
of the gene relative to the LCR [11].
Our previous study on the human b-globin PAC transgenes has
shown that 59HS5 is a stage-specific enhancer blocking element that
functions at the primitive stage of erythropoiesis [11]. Surprisingly,
we did not observe any significant alterations in the structure of the
b-globin locus by 3C analysis primitive embryonic blood when
59HS5 was deleted. The results obtained from both the definitive
and primitive stages imply that spatial organization of the locus is
essentially unchanged upon deletion of 59HS5 (PACD1B) or in the
double deletion of HS5 and the b-globin promoter (PACD3K). We
can not completely discount the possible influence of 59HS5 on b-
globin locus configuration as this might not be detectable due to
limitations of the resolution achieved with the 3C technique.
However, we can conclude that the enhancer blocking properties of
59HS5 in primitive erythroid cells is not accompanied by major
effects on the spatial organization of the b-globin locus.
Interestingly this study shows that CTCF, the first transcription
factor found to have insulating activity [28] and enhancer blocking
function [13,14] in mammalian cells, binds to the 59HS5 core
region at both the primitive and definitive stages in erythroid cells
in vivo. This indicates that CTCF could be involved in the border
function of 59HS5 in the primitive cells. Since it also binds to the
59HS5 region in definitive cells, this suggests that CTCF, most
likely in conjunction with other proteins, can have opposing effects
on gene expression. Filippova et al. [31] proposed that CTCF
could be a transcriptional repressor of the c-Myc oncogene in
vertebrates. In contrast, the CTCF protein can bind to the promoter
of the amyloid b protein precursor and activate transcription [32].
Figure 5. 3C analysis of the PAC3K and PACD3K transgenes using a primer from the human b-globin gene as the fixed primer.
Embryonic blood was collected from E10.5 embryo for this set of 3C experiment. (A) Representative expamples of the PCR fragments resulting from
the 3C experiments. RT: Random template control. (B) Histograms of the relative crosslinking efficiencies after quantitation and normalization.
doi:10.1371/journal.pone.0002134.g005
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Thus, CTCF could be a ‘‘dual functionality’’ protein that has
divergent effects on different gene regulation systems. In addition, we
show that CTCF binds to the bm gene in both primitive and
definitive stage. Three putative CTCF binding sites can be identified
at2133 to2149,21005 to2990 and21396 to21412 bp relative
to the cap site of the bm gene (Figure S1). Collectively, our results
indicate that CTCF may have a more general role in the regulation
of the b-globin locus than previously anticipated. Splinter et al. (2006)
[33] have recently shown that in CTCF null cells, there were
reduced DNA-DNA interaction frequencies between the sites that
normally bind CTCF in the mouse b-globin gene locus. Interest-
ingly, no changes were seen in the interaction of the surrounding
olfactory genes (MOR5B1-3 and MOR3B1-4 [33]), or the
expression level of the b-globin genes. It has been proposed
previously that CTCF and the chick HS4 insulator sequence are
highly concentrated in Matrix Attachment Regions (MARs) which
create separate ‘‘loop’’ domains that prevent the interaction between
an enhancer and promoter [34]. Collectively, these data suggested
that CTCF participates in more than one pathway in the regulation
of the globin genes.
Materials and Methods
Transgenic mice
PAC transgenic constructs (Fig. 1) containing the b-globin locus
were generated using homologous recombination in Escherichia coli
according to Iman et al. (2000) [15]. Modified PACs were used to
generate transgenic mice; these mice have been characterized
extensively in Wai et al. (2003) [11].
Tissues used for 3C
Plugged transgenic mice were sacrificed and the embryos were
collected at 10.5 and 14.5 dpc (day post coitum) respectively. Fetal
liver and brain were collected from 14.5 dpc embryos, and
embryonic blood and head were collected at 10.5 dpc. as
previously described [6,7,35].
Preparation of 3C templates
The 3C protocol was adapted fromTolhuis et al. (2002) [6]. 16107
cells was defined as 1 unit of sample in a 10ml crosslinking reaction
(2% formaldehyde in DMEM with 10% FCS). The samples were
cross-linked for 10 minutes at room temperature with gentle mixing.
The reaction was quenched by the addition of glycine to 0.125M.
Nuclei were harvested by lysis of the cells in 5ml ice-cold lysis buffer
(10mM Tris-Cl, 10mM NaCl, 0.2% NP-40 pH8.0) containing
protease inhibitors (pefabloc, Roche) for 10 minutes on ice. Nuclei
were resuspended in 0.5ml 16HindIII restriction buffer (Roche)
containing 0.3% SDS and incubated for 1 hour at 37uC with
agitation. Triton X-100 was added to 2% (v/v), and the nuclei were
further incubated for 1 hour at 37uC to sequester the SDS. The
crosslinked DNA was digested overnight at 37uC with 400U
HindIII. The restriction enzyme was inactivated by the addition of
SDS to 1.6% and incubated at 65uC for 20 minutes with agitation.
The reaction was diluted with 7ml 16ligation buffer (Promega) and
incubated for 1 hour at 37uC. The chromatin was ligated with 100U
T4 DNA ligase (Promega) for 4 hours at 16uC followed by
30 minutes at room temperature. 600 mg of Proteinase K was
added, and samples were incubated overnight at 65uC to reverse the
cross-links. Next, the samples were incubated for 30 minutes at 37uC
with 1500 mg of DNase-free RNaseA, and the DNA was purified by
phenol extraction and ethanol precipitation. The DNA pellet was
resuspended in 150 ml 10 mM Tris-Cl (pH7.5).
Preparation of Random Template control
In order to normalize the amplification efficiency of different
primer sets, the PAC185 [15] plasmid containing the human b-
globin locus was used for preparation of the random template
control (RTC). Theoretically, this random template control
contains all possible ligation products in equimolar amounts.
Wild-type mouse genomic DNA was mixed with PAC185 plasmid
and a 60–70kb PAC containing the mouse XPB locus (PAC Clone
#443-C18, MRC gene services). The genomic DNA/PAC clones
mixture was processed according to the 3C technique [6].
The processed products were serially diluted with wild-type
mouse genomic DNA until the PAC DNA was present in a molar
ratio similar to single-copy b-globin locus transgenic DNA (line
PAC8.1), as assessed by quantitative PCR [6,7]. PCR products
were run on a 2% agarose gel and quantified with a Typhoon
9200 imager (Amersham). Typically 300ng of DNA was
subsequently used for each 3C-PCR reaction. Each PCR reaction
was performed in triplicate and repeated at least three times.
Sequences of the 3C PCR primers are shown in Table 1.
Anti-CTCF ChIP assays
16107 cells were defined as 1 unit of sample for 10ml ChIP
crosslinking reaction (2% formaldehyde and 40mM HEPES
pH7.9 in DMEM with 10% FCS). The samples were crosslinked
for 20 minutes at room temperature with gentle mixing. The
reaction was quenched by the addition of glycine to 0.125M. The
cells were harvested by centrifugation at 1500rpm for 5 minutes at
4uC. The cells were first washed with PBS buffer containing
protease inhibitors (1 mM phenylmethylsulfonyl fluoride (PMSF),
1 mg/ml aprotinin and 1 mg/ml pepstatin A) and centrifuged at
1500rpm for 5 minutes. 10 ml of Triton-wash buffer (0.25%
Triton-X 100, 10mM Na-EDTA, 0.5 mM Na-EGTA and 10 mM
Tris-Cl pH8.0) was added and the samples were incubated at
room temperature for 10 minutes. The cells were pelleted by
centrifugation at 1500rpm for 5 minutes and they were further
washed with 10ml NaCl-wash (200mM NaCl, 1 mM Na-EDTA,
0.5mM Na-EGTA and 10mM Tris-Cl pH8.0) buffer at room
temperature for 10 minutes. After centrifugation at 1500rpm for
5 minutes, the pellet was resuspended in 500 ml sonication buffer
(1mM Na-EDTA, 0.5mM Na-EGTA and 10mM Tris-Cl pH8.0)
and kept on ice for 5 minutes. DNA was sheared by sonication to
lengths between 200 and 1000bp, keeping the sample cold on ice.
Cell debris was removed by centrifugation. ChIP reactions were
performed according to the Upstate Biotechnology chromatin
immunoprecipitation protocol with 1 mg of anti-CTCF antibody
(Upstate Biotechnology) per IP reaction. Enrichment of specific
Figure 6. CTCF-ChIP assay analysis of the binding of CTCF
protein to the mouse HS62 (mHS62), bm and human 59HS5 in
the primitive (A) and definitive (B) stage. Fold enrichment of the
test sequence in bound with CTCF versus input/starting material is
shown on the y axis.
doi:10.1371/journal.pone.0002134.g006
h59HS5 Is b-ACh Dispensable
PLoS ONE | www.plosone.org 7 May 2008 | Volume 3 | Issue 5 | e2134
immunoprecipitated sequences, including 59HS5, bm (marked b-
globin gene), mHS62 (mouse HS62) and a fragment of the mouse
Necdin gene (control), were determined by real-time PCR. Fold
enrichment was calculated by comparing the ratio to Necdin in pull-
down-eluate against the value from input-starting material. The
sequences of the ChIP PCR primers are shown in Table 2. The
location of the bm gene primers were shown in Fig. 1B.
Supporting Information
Figure S1 Alignment of the cHS4 CTCF binding site with the bm
promoter. Alignment of the cHS4 CTCF binding site with the bm
promoter (1). The bm gene cap site (+1) are indicated with a blue
letters. The proposed CTCF binding sites in the bm sequence are
indicated with red letters and the cHS4 CTCF binding sequence is
shown on top of each proposed binding site. Conserved binding
sequences are highlighted with a gray background. The alignment
was performed with the ClustalX program (2) Reference List 1.
Farrell CM, West AG, Felsenfeld G (2002) Conserved CTCF
insulator elements flank the mouse and human beta-globin loci. Mol
Cell Biol 22: 3820-3831. 2. Thompson JD, Gibson TJ, Plewniak F,
Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows
interface: flexible strategies for multiple sequence alignment aided by
quality analysis tools. Nucleic Acids Res 25: 4876-4882.
Found at: doi:10.1371/journal.pone.0002134.s001 (0.04 MB
DOC)
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